TrialMatchAI

by TrialMatchAI — AI-powered matching connecting patients to life-changing clinical trials — in under 30 seconds.
Hematology Internal Medicine Oncology

Free for basic features; pro plan for advanced features.
Regulatory Status Disclosed

Overview

TrialMatchAI is an AI-powered recommendation system designed to automate and streamline the process of matching patients to eligible clinical trials. It is primarily intended for use by physicians and research staff in care settings such as academic and community hospitals, particularly in specialties like oncology, where identifying suitable trials can be complex and time-consuming.

  • What it does: TrialMatchAI processes heterogeneous clinical data, including structured records and unstructured physician notes, alongside clinical trial metadata and eligibility criteria. It uses natural language processing (NLP) and large language models (LLMs) to extract and normalize biomedical entities, retrieve candidate trials, and then assess criterion-level eligibility to generate a ranked list of personalized clinical trial recommendations.
  • How it fits a clinical or practice workflow: The tool integrates into existing clinical workflows, allowing physicians to input patient profiles in natural language or through standardized data formats like Phenopackets. It provides match rationales and explanations for eligibility, aiming to reduce the manual burden of trial discovery and accelerate patient recruitment. The system can be deployed on local infrastructure, ensuring patient data remains within the user’s environment.
  • Notable capabilities: TrialMatchAI offers explainable AI-driven decision-making by generating concise explanations for each criterion-level classification. It supports a hybrid search approach combining text-based retrieval with vector search for efficient identification of relevant trials. The system is modular and open-source, allowing for customization and updates to its LLM components.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AI-powered patient-to-trial matching
  • Processes structured and unstructured clinical data
  • Leverages fine-tuned, open-source Large Language Models (LLMs)
  • Retrieval-Augmented Generation (RAG) framework
  • Transparency and reproducibility with explainable outputs
  • Secure local deployment within hospital infrastructures
  • Normalizes biomedical entities and standardizes terminology
  • Hybrid search strategy combining lexical and semantic similarity
  • Criterion-level eligibility assessments using medical Chain-of-Thought reasoning
  • Supports Phenopackets-standardized data

Use Cases

  • Automating patient recruitment for clinical trials
  • Identifying eligible patients for biomarker-driven oncology trials
  • Streamlining recruitment for long or multi-phase clinical studies
  • Optimizing patient interest and matching activity across multi-site studies
  • Reducing administrative burden for research staff
  • Expanding access to experimental therapies for patients

What Physicians Need to Know

Clinical Trial Matching
TrialMatchAI is an AI-powered recommendation system that automates patient-to-trial matching by processing heterogeneous clinical data, including structured records and unstructured physician notes. It leverages fine-tuned, open-source Large Language Models (LLMs) within a Retrieval-Augmented Generation (RAG) framework. The system has demonstrated high accuracy, with over 90% in criterion-level eligibility classification, particularly excelling in biomarker-driven matches. In real-world validation, 92% of oncology patients had at least one relevant trial retrieved within the top 20 recommendations. It supports various patient data inputs like free-text notes, Phenopacket JSON, HL7 FHIR R4 bundles, and OMOP CDM extract folders. The platform provides a ranked shortlist of trials with explanations for each criterion, detailing why a patient does or does not qualify.
Genomic Data Integration
TrialMatchAI is designed to integrate and interpret diverse clinical, molecular, and genetic data, including biomarker expression profiles and genomic mutations, to facilitate patient-trial matching. This capability is crucial for identifying patients whose genetic profiles make them ideal candidates for specific trials, advancing precision medicine.
Literature Mining
The system normalizes biomedical entities using Named Entity Recognition (NER) and entity normalization, mapping extracted entities to biomedical vocabularies like MeSH, OMIM, ChEBI, Cell Ontology, NCBI Gene, and UMLS. It processes structured trial metadata from sources like clinicaltrials.gov and patient records. TrialMatchAI uses a hybrid search strategy combining lexical and vector search via Elasticsearch to identify a broad pool of relevant trials.
Target Identification
While TrialMatchAI primarily focuses on clinical trial matching, the integration of genomic data and the ability to understand underlying disease mechanisms can indirectly support target identification by highlighting patient subgroups that would benefit most from therapeutic intervention on specific targets.
Safety Signal Detection
TrialMatchAI's core functionality is patient-to-trial matching and does not explicitly highlight features for safety signal detection in drug discovery or post-marketing surveillance. However, the processing of heterogeneous clinical data could potentially contribute to identifying adverse events or trends if such analysis were integrated. Dedicated pharmacovigilance platforms like SafetySignal AI automate adverse event detection, causality assessment, and regulatory reporting.
Collaboration Features
The provided information does not explicitly detail collaboration features within TrialMatchAI. However, its open-source and modular design, along with the ability to generate explainable outputs, could facilitate collaboration among researchers and clinicians.
Publication Support
TrialMatchAI is an open-source system, and its methodology and evaluation results have been published in research papers, demonstrating its contribution to the scientific community. The system's explainable outputs with traceable decision rationales can support the transparency and reproducibility required for publications.
Physician Tip

For physicians, TrialMatchAI can significantly streamline the process of identifying suitable clinical trials for patients, especially in complex cases like oncology where biomarker-driven matches are critical. The system's ability to process both structured and unstructured clinical data, including physician notes, reduces the manual burden of sifting through extensive patient records and trial protocols. The explainable outputs, detailing why a patient is or isn't eligible for a particular trial, can enhance trust and facilitate informed discussions with patients. Integrating this tool into routine oncology workflows can improve screening efficiency and patient access to trials. However, it's important to remember that TrialMatchAI is a recommendation system and should not replace review by qualified healthcare professionals.

TrialMatchAI is designed for secure local deployment and supports Phenopackets-standardized data, facilitating semantic interoperability. It ingests structured trial metadata from sources like clinicaltrials.gov and patient records. The system utilizes Elasticsearch for efficient retrieval and is built with fine-tuned, open-source Large Language Models (LLMs) like Gemma-2-2B and Phi-4, allowing for seamless replacement of LLM components as more advanced models emerge. It can import patient data in various formats, including free-text notes (.txt, .md), GA4GH Phenopacket JSON, HL7 FHIR R4 bundles, individual FHIR resources, NDJSON, JSONL, and OMOP CDM extract folders with CSV or Parquet tables. The system can be installed via PyPI and offers a command-line interface (CLI) for various functionalities.

Details

Category Drug Discovery & Research, Oncology AI
Pricing Free for basic features; pro plan for advanced features.
DeploymentLocal deployment on a single Python 3.11 GPU server or VM.
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Not applicable AI-estimated
Integrations
EHR Not specified
Specialties Hematology, Internal Medicine, Oncology

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate TrialMatchAI

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for TrialMatchAI.

View all on YouTube

Frequently Asked Questions

TrialMatchAI employs robust encryption protocols and anonymization techniques to protect patient data. It is designed to be fully compliant with HIPAA, GDPR, and other relevant data privacy regulations, ensuring that all data used in drug discovery research is handled securely and ethically.
TrialMatchAI significantly streamlines patient recruitment by leveraging AI to identify eligible candidates more efficiently, reducing the time and cost associated with clinical trials. It also enhances the diversity of trial participants and improves the overall success rates of drug discovery research by matching the right patients to the right trials.
While several platforms aim to improve clinical trial efficiency, TrialMatchAI distinguishes itself through its advanced AI algorithms for predictive analytics and real-world data integration. Other solutions may offer components of patient matching or trial management, but few integrate these as comprehensively for drug discovery as TrialMatchAI.
TrialMatchAI typically offers tiered pricing models that can vary based on the scale of drug discovery research, the number of active clinical trials, and the specific features required. Custom enterprise solutions are also available for larger research institutions and pharmaceutical companies. Specific pricing details can be obtained through a direct consultation.
While highly effective, TrialMatchAI's performance is dependent on the quality and availability of input data. Limitations can include challenges with integrating disparate data sources, the need for initial setup and customization, and the ongoing requirement for data governance to maintain accuracy and relevance in drug discovery research.
TrialMatchAI is designed with interoperability in mind, offering APIs and integration capabilities to connect with various EHR and CTMS platforms. This allows for seamless data flow, reducing manual data entry and improving the efficiency of patient identification and trial management within drug discovery research.
Yes, TrialMatchAI's advanced algorithms are particularly adept at identifying niche patient populations, including those for rare diseases or trials with highly specific inclusion/exclusion criteria. Its ability to analyze vast datasets helps uncover potential candidates that might be missed by traditional methods, significantly aiding drug discovery research in these challenging areas.

Related Tools

AIRA
AIRA Healthcare
Drug Discovery & Research
AIRA is an AI platform for study design and protocol development, providing expert-level clinical, regulatory, and medical writing AI thought partners to accelerate clinical development workflows.
Biomiv
Cymetica Biosciences
Clinical Decision Support & Reference
Biomiv is an AI health research assistant that provides physicians with insights into health conditions, engineered diets, and live scientific papers and clinical trials.
TrialGPT
National Institutes of Health (NIH)
Drug Discovery & Research
An AI algorithm developed by NIH researchers to speed up the process of matching potential volunteers to relevant clinical research trials listed on ClinicalTrials.gov.
InsightRX
InsightRX
Drug Discovery & Research
InsightRX offers AI-powered precision medicine software for clinical development and point-of-care, combining agentic AI, pharmacometrics, and real-world data to enable smarter, more precise decisions for health systems and life sciences teams.
Indica Labs HALO AI
Indica Labs
Drug Discovery & Research
HALO AI is a deep-learning add-on for the HALO image analysis platform, helping users solve image analysis challenges in segmentation, classification, and phenotyping for research.
Triomics
Triomics
Clinical Decision Support & Reference
Triomics is an AI-powered platform that streamlines clinical trial matching and oncology research by integrating with EHRs to identify eligible cancer patients.

See all Drug Discovery & Research tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-08-23 | First Added: 2026-08-23
AI Tool Finder
AI-powered search. Results may not be comprehensive.